financetom
Business
financetom
/
Business
/
Essex Property Trust Reports Tax Treatment for 2024 Dividend Payments
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Essex Property Trust Reports Tax Treatment for 2024 Dividend Payments
Jan 15, 2025 2:33 PM

05:13 PM EST, 01/15/2025 (MT Newswires) -- Essex Property Trust ( ESS ) on Wednesday announced the income tax treatment for its 2024 dividend payments.

The company said it paid a total of $9.66 per share in dividends for 2024, with four quarterly payments that include $2.31 in January, $2.45 in April, $2.45 in July, and $2.45 in October.

Out of the total, 98.191%, or $9.48525 is deemed an ordinary taxable dividend, while 1.809%, or $0.17475 is categorized as a capital gain.

The distributions consist of $9.48525 in Section 199A dividends and $0.17475 in Section 897 gains, the company said.

Essex said it did not incur any foreign taxes in 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--MDU Ups Quarterly Dividend to $0.13/Share From $0.125, Payable Oct. 1 to Holders of Record on Sept. 12
--MDU Ups Quarterly Dividend to $0.13/Share From $0.125, Payable Oct. 1 to Holders of Record on Sept. 12
Aug 15, 2024
04:57 PM EDT, 08/15/2024 (MT Newswires) -- Price: 25.52, Change: +1.22, Percent Change: +5.02 ...
Alvotech H1 Loss Widens, Revenue Increases; Full-Year Guidance Reaffirmed
Alvotech H1 Loss Widens, Revenue Increases; Full-Year Guidance Reaffirmed
Aug 15, 2024
04:56 PM EDT, 08/15/2024 (MT Newswires) -- Alvotech ( ALVO ) reported an H1 loss late Thursday of $0.61 per diluted share, widening from a loss of $0.39 a year earlier. Revenue for the six months ended June 30 was about $235.6 million, compared with $20.3 million a year earlier. Analysts' estimates were unavailable for comparison. Alvotech ( ALVO )...
Atlassian Insider Sold Shares Worth $1,141,067, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,141,067, According to a Recent SEC Filing
Aug 15, 2024
04:54 PM EDT, 08/15/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on August 14, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,141,067. Following the Form 4 filing with the SEC, Farquhar has control over a total of 254,336 shares of the company, with 254,336 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006287/xslF345X03/primarydocument.xml Price: 146.00, Change: -0.83, Percent...
Incyte Cancer Treatment Candidate Meets Primary Goal in Study
Incyte Cancer Treatment Candidate Meets Primary Goal in Study
Aug 15, 2024
04:55 PM EDT, 08/15/2024 (MT Newswires) -- Incyte ( INCY ) said Thursday that its cancer drug Monjuvi met the primary goal of phase 3 study by showing progression-free survival in patients with relapsed or refractory follicular lymphoma. Incyte ( INCY ) was evaluating Monjuvi, or tafasitamab, in combination with lenalidomide and rituximab in the study, according to the company....
Copyright 2023-2026 - www.financetom.com All Rights Reserved